KOBV Portal

Hits per page

hits 1 - 2 | 2 hits

Sorting

Article

Aurora kinases as targets in drug-resistant neuroblastoma cells (2014)

Martin Michaelis ; Florian Selt ; Florian Rothweiler ; [et al.]

add to watchlist on the watchlist

Details

Language: English

In: PLoS ONE, 01 January 2014, Vol.9(9), p.e108758

Description: Aurora kinase inhibitors displayed activity in pre-clinical neuroblastoma models. Here, we studied the effects of the pan-aurora kinase inhibitor tozasertib (VX680, MK-0457) and the aurora kinase inhibitor alisertib (MLN8237) that shows some specificity for aurora kinase A over aurora kinase...

Keywords: Sciences (General)

E-ISSN: 1932-6203

DOI: 10.1371/journal.pone.0108758

URL: View full text in DOAJ

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Article

Online access

Open Access Request

Article

Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen (2015)

Martin Michaelis ; Bishr Agha ; Florian Rothweiler ; [et al.]

add to watchlist on the watchlist

Details

In: Scientific Reports, 2015, Vol.5

Description: Flubendazole was shown to exert anti-leukaemia and anti-myeloma activity through inhibition of microtubule function. Here, flubendazole was tested for its effects on the viability of in total 461 cancer cell lines. Neuroblastoma was identified as highly flubendazole-sensitive cancer entity in a screen of 321 cell lines from 26 cancer entities. Flubendazole also reduced the viability of five primary neuroblastoma samples in nanomolar concentrations thought to be achievable in humans and inhibited vessel formation and neuroblastoma tumour growth in the chick chorioallantoic membrane assay. Resistance acquisition is a major problem in high-risk neuroblastoma. 119 cell lines from a panel of 140 neuroblastoma cell lines with acquired resistance to various anti-cancer drugs were sensitive to flubendazole in nanomolar concentrations. Tubulin-binding agent-resistant cell lines displayed the highest flubendazole IC50 and IC90 values but differences between drug classes did not reach statistical significance. Flubendazole induced p53-mediated apoptosis. The siRNA-mediated depletion of the p53 targets p21, BAX, or PUMA reduced the neuroblastoma cell sensitivity to flubendazole with PUMA depletion resulting in the most pronounced effects. The MDM2 inhibitor and p53 activator nutlin-3 increased flubendazole efficacy while RNAi-mediated p53-depletion reduced its activity. In conclusion, flubendazole represents a potential treatment option for neuroblastoma including therapy-refractory cells.

Keywords: Biology;

ISSN: 20452322

E-ISSN: 20452322

DOI: 10.1038/srep08202

URL: View this record in Nature

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Article

Online access

Open Access Request

hits 1 - 2 | 2 hits

Nothing or not found what you are looking for? Please check your search query or use the Interlibrary Loan Search.

Kooperativer Bibliotheksverbund

Berlin Brandenburg